Experienced leader will head Quality & Compliance function at leading
contract research organization
KING OF PRUSSIA, PA, June 26 /CNW/ - MDS Pharma Services, a leading
provider of innovative drug discovery and development solutions, has hired Dr.
Lori McDonald as Vice President, Quality & Compliance. Dr. McDonald will lead
MDS Pharma Services' ongoing program to build and manage quality and
regulatory compliance systems across its global business platforms.
"I'm delighted that Dr. McDonald has joined our leadership team," said
MDS Pharma Services President David Spaight. "By enabling process improvements
and compliance with regulatory requirements, she and her staff will be
instrumental in helping MDS Pharma Services deliver high-quality, on-time
services. This will help our clients expedite their drug discovery and
Dr. McDonald brings strong credentials to this key leadership position.
Before joining MDS she served as Vice President, Regulatory Affairs with Alder
Biopharmaceuticals. From 2001 to 2006, Dr. McDonald held a series of
leadership roles with Cardinal Health, culminating as Executive Director,
Regulatory Affairs. Prior to that, she worked at Ligand Pharmaceuticals and
Dr. McDonald holds a B.S. in Medical Technology from the University of
North Dakota, and both an M.S. and a Ph. D. in Pharmaceutics from the
University of Michigan. She also holds a Regulatory Affairs Certification,
which is administered by the Regulatory Affairs Professionals Society.
About MDS Pharma Services
MDS Pharma Services is committed to delivering quality service on time.
We offer a full spectrum of resources to meet the drug discovery and
development needs of the pharmaceutical and biotechnology industries. With
numerous facilities strategically located around the world, we apply advanced
scientific and technological expertise throughout the drug discovery and
development process - from lead optimization, pre-IND research, early clinical
research (bioequivalence, phases I-IIa) and bioanalysis through to global
clinical development (phases IIb-IV), central lab and centralized cardiac
services. For more information, visit our website at www.mdsps.com.
MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ),
a global life sciences company that provides market-leading products and
services that our customers need for the development of drugs and diagnosis
and treatment of disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging, radiotherapeutics,
and analytical instruments. MDS has more than 5,500 highly skilled people in
29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222,
24 hours a day.
For further information:
For further information: For Investors: Kim Lee, (416) 675-6777 ext.
34721, email@example.com; For Media: Charlene McGrady, (610) 239-7900 ext.